Geographically, North America dominates the theranostics market driven by best in class healthcare and pharmaceutical infrastructure, best in industry practices, strict regulation and high degree of adherence to the rules and guidelines. North America was followed by Europe and Asia-Pacific as second and third largests market for the theranostics market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, newer regulations implementations by governing bodies, and increasing awareness amongst population in developing nations such as China and India in this region.
This report identifies the global theranostics market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the theranostics market.
This report segments the theranostics market on the basis of diseases and regional market as follows:
Theranostics Market research report is classified on the basis of diseases. Some of the major diseases covered in this report are as follows: Neuro Disorders, Cancers and Cardiovascular diseases
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the theranostics market. Some of the major companies' profiles in detail are as follows:
Dickinson & Company
Download the full report: https://www.reportbuyer.com/product/4399371/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/theranostics-market-by-disease-neuro-disorders-cancers-and-cardiovascular-diseases--by-region--forecast-2016-2021-300380725.html